These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2004-004231-53||The Effect Of Antihypertensive Treatment With Lisinopril and Labetalol on Baroreflex Sensitivity in Stroke||2010-05-30||due-trials|
|Not reported||2005-000656-33||A Phase I/II Study of Sirolimus (Rapamune TM) in Combination with Cyclophosphamide and Dexamethasone in Relapsed Myeloma||2009-06-10||due-trials|
|Completed, but no date Terminated||2005-002247-86||Peripheral Blood Stem Cell Mobilisation with Cyclophosphamide and Methylprednisolone in Patients with Myeloma and Indolent Lymphoma– a prospective single arm study with historical controls||bad-data|
|Not reported||2006-001808-37||A randomised controlled trial of fentanyl versus morphine following lower limb arthroplasty||2009-05-30||due-trials|
|Not reported||2009-013100-32||Does modulating the gut hormones, incretins, modify vascular function, thereby reducing the risk of vascular complications in insulin resistant individuals?||2012-06-15||due-trials|
|Not reported||2010-019953-16||A Preliminary Randomised Controlled Trial using Standard Therapy Vs Mugard||2013-09-16||due-trials|
|Not reported||2010-023262-46||A Randomised Prospective Pilot Study Comparing the Outcomes of Patients with Lumbar Nerve Root Pain Secondary to Lumbar Disc Prolapse Treated by Nerve Root Block with or without the Addition of Clonid...||2014-08-14||due-trials|
|Ongoing||2011-003572-36||The role of GLP-1 analogues in reducing reperfusion injury after acute stroke in patients with impaired swallowing.||not-yet-due|
|Not reported||2015-002176-25||Do ultrasound guided botulinum A injections relieve pain in rotator cuff arthropathy?||2017-11-22||due-trials|
|Ongoing||2015-002790-38||TriMaster: Randomised Double-Blind Crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as third line therapy in patients with type 2 diabetes who have suboptimal glycaemic contr...||not-yet-due|
|Ongoing||2016-001530-10||A randomised controlled trial of topical intranasal tranexamic acid versus placebo to reduce the need for nasal packing in patients presenting to the Emergency Department with spontaneous epistaxis.||not-yet-due|